NCCAM on ephedra
This article was originally published in The Tan Sheet
Executive Summary
NIH center is considering sponsoring a case-control study on adolescents' use of ephedra for weight-loss and/or performance enhancement. Story on p. 9 of 1"The Tan Sheet" March 24, 2003 implied NCCAM would limit research to the herbal's use for performance enhancement...
You may also be interested in...
Ephedra Case-Control Study Supported By NCCAM Advisory Council
A motion recommending that NCCAM initiate a "case-control study...among adolescents and young adults using ephedra for performance enhancement" passed the center's National Advisory Council for Complementary & Alternative Medicine by a 7-3 vote
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.